M
Michael R. Green
Researcher at University of Texas MD Anderson Cancer Center
Publications - 597
Citations - 65007
Michael R. Green is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: RNA splicing & RNA. The author has an hindex of 126, co-authored 537 publications receiving 57447 citations. Previous affiliations of Michael R. Green include Eppley Institute for Research in Cancer and Allied Diseases & United States University.
Papers
More filters
Journal ArticleDOI
Labeling the 3' Termini of Oligonucleotides Using Terminal Deoxynucleotidyl Transferase
Michael R. Green,Joseph Sambrook +1 more
TL;DR: A template-independent terminal deoxynucleotidyl transferase (TdT) as mentioned in this paper is a template independent polymerase that catalyzes the addition of deoxysucleotides and dideoxyn nucleotides to the 3'-hydroxyl terminus of a DNA molecule.
Journal ArticleDOI
Total RNA Extraction from Saccharomyces cerevisiae Using Hot Acid Phenol.
Michael R. Green,Joseph Sambrook +1 more
TL;DR: In this paper, the authors used a cycle of heating and freezing of cells in the presence of phenol and the detergent sodium dodecyl sulfate (SDS) to extract RNA from yeast.
Journal ArticleDOI
Updates in combined approaches of radiotherapy and immune checkpoint inhibitors for the treatment of breast cancer
Kassidy M. Jungles,Erin A Holcomb,Ashley N Pearson,Kalli R. Jungles,Caroline R. Bishop,Lori J. Pierce,Michael R. Green,Corey Speers +7 more
TL;DR: This review will discuss the mechanisms supporting combined approaches with radiotherapy and immune checkpoint inhibitors for the treatment of breast cancer, and analyze the current clinical trials examining combined approaches of radiotherapy, immunotherapy, chemotherapy, and targeted therapy.
Journal ArticleDOI
CBX5 loss drives EGFR inhibitor resistance and results in therapeutically actionable vulnerabilities in lung cancer
TL;DR: In this paper , the authors showed that CBX5-E2F1-BIRC5 axis can be used for treating EGFRi-resistant lung cancer patients with acquired drug resistance.
Journal ArticleDOI
Harnessing the DNA Repair Pathway in Breast Cancer: Germline Mutations/Polymorphisms in Breast Radiation.
TL;DR: In this article , the available data on germline mutations and polymorphisms in breast cancer were reviewed and their association with treatment tolerance, locoregional outcomes, and ongoing efforts to transform these insights into more effective treatment strategies in combination with radiotherapy.